靶向食管鳞状细胞癌中的Bcl-xL，使其对化疗加TRAIL诱导的凋亡敏感，同时通过阻断半胱天冬酶9来保护正常上皮细胞。 - Suppr

Suppr

超能文献

Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9.

作者信息

Kim K, Nakagawa H, Fei P, Rustgi A K, El-Deiry W S

出版信息

Cell Death Differ. 2004 May;11(5):583-7. doi: 10.1038/sj.cdd.4401388.

DOI:10.1038/sj.cdd.4401388

PMID:14752513

Abstract

摘要

相似文献

Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9.

Cell Death Differ. 2004 May;11(5):583-7. doi: 10.1038/sj.cdd.4401388.

Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.

Int J Oncol. 2004 Oct;25(4):1171-81.

Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.

Cancer Res. 2004 Nov 1;64(21):8036-44. doi: 10.1158/0008-5472.CAN-04-0762.

Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.

Clin Cancer Res. 2004 Oct 1;10(19):6650-60. doi: 10.1158/1078-0432.CCR-04-0576.

Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells.

Cancer Res. 2004 May 15;64(10):3607-16. doi: 10.1158/0008-5472.CAN-03-3648.

Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.

Cancer Res. 2005 Aug 15;65(16):7436-45. doi: 10.1158/0008-5472.CAN-04-2628.

Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.

Cancer Res. 2005 Mar 15;65(6):2344-52. doi: 10.1158/0008-5472.CAN-04-3502.

Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.

Prostate. 2004 Sep 15;61(1):35-49. doi: 10.1002/pros.20069.

Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.

Vitam Horm. 2004;67:453-83. doi: 10.1016/S0083-6729(04)67023-3.

Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.

Gynecol Oncol. 2004 Jun;93(3):594-604. doi: 10.1016/j.ygyno.2004.03.029.

引用本文的文献

Therapeutic targeting of TRAIL death receptors.

Biochem Soc Trans. 2023 Feb 27;51(1):57-70. doi: 10.1042/BST20220098.

Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor‑related apoptosis‑inducing ligand‑induced oral squamous cell carcinoma apoptosis and suppresses proliferation in vitro and in vivo.

Int J Mol Med. 2018 Sep;42(3):1283-1294. doi: 10.3892/ijmm.2018.3721. Epub 2018 Jun 7.

IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment.

Am J Cancer Res. 2014 Jan 15;4(1):29-41. eCollection 2014.

Resistance to TRAIL is mediated by DARPP-32 in gastric cancer.

Clin Cancer Res. 2012 Jul 15;18(14):3889-900. doi: 10.1158/1078-0432.CCR-11-3182. Epub 2012 May 15.

Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.

Mol Cancer Ther. 2010 Jun;9(6):1842-51. doi: 10.1158/1535-7163.MCT-09-0918. Epub 2010 Jun 1.

TRAIL recombinant adenovirus triggers robust apoptosis in multidrug-resistant HL-60/Vinc cells preferentially through death receptor DR5.

Hum Gene Ther. 2008 Jul;19(7):731-43. doi: 10.1089/hum.2008.001.

The combination of TRAIL treatment and cancer cell selective expression of TRAIL-death receptor DR4 induces cell death in TRAIL-resistant cancer cells.

Yonsei Med J. 2006 Feb 28;47(1):55-62. doi: 10.3349/ymj.2006.47.1.55.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验